6th Annual Pharma Packaging and Labeling USA 201426-27 February 2014, Philadelphia, USA
The 6th year of a truly successful and respected Pharma Packaging and Labeling event is rolling back into town with this year expected to be bigger than ever.
With key legislation on the horizon in California and the counterfeiting market now worth millions of dollars as well as sustainability and green packaging in demand, the need for this event is heightened.
We aim to bring you more compelling speakers talking about the subjects that matter to you. Following extensive research into the market we have been able identify key themes to discuss, issues to debate and people you want to meet all under one roof.
This outstanding event will provide a fantastic opportunity for exhibitors to promote their products and services to senior level decision makers from the region. Exhibition spaces are filling up due to the success of last year’s event as well as the global reputation of this world-renowned series.
Pharma Packaging and Labeling 2014 aims to target specific areas of the market in an interesting and insightful manner.
Rondo Pak would like to welcome all attendees of Pharma Packaging and Labeling to their drink reception taking place at the end of day one, on the 26th of February.
The UK National Institute for Health and Clinical Excellence (NICE) has recommended Ferring Pharmaceuticals' Firmagon (degarelix) as an option for treating advanced hormone-dependent prostate cancer.
BioAlliance Pharma and Topotarget have announced a merger agreement with an aim to create an orphan oncology company with increased scale and a highly complementary pipeline of late-stage products targeting significant unmet medical needs.
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) Tanzeum (albiglutide) subcutaneous injection to improve glycaemic control, diet and exercise in adults with type 2 diabetes.
Merck has obtained approval from the US Food and Drug Administration (FDA) for its Grastek (Timothy grass pollen allergen extract) sublingual tablet as immunotherapy for treatment of grass pollen-induced allergic rhinitis with or without conjunctivit…
The Chemistry, Food & Drugs Division of the Trinidad and Tobago Ministry of Health has approved Janssen's first orally administered androgen synthesis inhibitor (testosterone) medication 'Abiraterone Acetate' in the country for treatment of patients …